New evidence suggests that the mechanism of nanoparticle entry into solid tumours may be driven by an active process. This insight paves the way for approaches to enhance the efficiency of nanomedicine delivery by harnessing active transport mechanisms, and encourage researchers to rethink how tumours are treated.
References
Chan, W. C. W. Acc. Chem. Res. 50, 627–632 (2017).
Nakamura, H., Jun, F. & Maeda, H. Expert Opin. Drug Deliv. 12, 53–64 (2015).
Wilhelm, S. et al. Nat. Rev. Mater 1, 16014 (2016).
Shi, J., Kantoff, P., Wooster, R. & Farokhzad, O. C. Nat. Rev. Cancer 17, 20–37 (2017).
Sindhwani, S. et al. Nat. Mater. https://doi.org/10.1038/s41563-019-0566-2 (2020).
Hobbs, S. K. et al. Proc. Natl Acad. Sci. USA 95, 4607–4612 (1998).
Schnitzer, J. E. Am. J. Physiol. Heart Circ. Physiol. 262, H246–H254 (1992).
Dvorak, H. F., Nagy, J. A., Dvorak, J. T. & Dvorak, A. M. Am. J. Pathol. 133, 95–109 (1988).
Oh, P. et al. Nat. Med. 20, 1062–1068 (2014).
Liu, Y. et al. Nano Lett. 19, 8010–8020 (2019).
Detampel, P. et al. PloS ONE 14, e0223339 (2019).
Ayloo, S. & Gu, C. Curr. Opinion Neurobiol. 57, 32–38 (2019).
Wiley, D. T., Webster, P., Gale, A. & Davis, M. E. Proc. Natl Acad. Sci. USA 110, 8662–8667 (2013).
Zhou, Q. et al. Nat. Nanotechnol. 14, 799–809 (2019).
Ruan, G., Agrawal, A., Marcus, A. I. & Nie, S. J. Am. Chem. Soc. 129, 14759–14766 (2007).
Ruoslahti, E. Adv. Drug Deliv. Rev. 110–111, 3–12 (2017).
Schmid, D. et al. Nat. Commun. 8, 1747 (2017).
Ledford, H. Nature 497, 544–544 (2013).
Syn, N. L., Teng, M. W. L., Mok, T. S. K. & Soo, R. A. Lancet Oncol. 18, e731–e741 (2017).
Jiang, W. et al. Nat. Biomed. Eng. 1, 0029 (2017).
Reinhard, K. et al. Science 367, 446–453 (2020).
Sahin, U. et al. Nature 547, 222–226 (2017).
Yuan, H. et al. Nat. Nanotechnol. 12, 763–769 (2017).
Chen, Q. et al. Nat. Commun. 7, 13193 (2016).
Kulkarni, A. et al. Proc. Natl Acad. Sci. USA 113, E2104–E2113 (2016).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Pandit, S., Dutta, D. & Nie, S. Active transcytosis and new opportunities for cancer nanomedicine. Nat. Mater. 19, 478–480 (2020). https://doi.org/10.1038/s41563-020-0672-1
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41563-020-0672-1
- Springer Nature Limited
This article is cited by
-
Hybrid transcytosis nanopomegranates for sensitizing breast cancer radiotherapy in deep tumor tissue
Nano Research (2023)
-
Peptide-based semiconducting polymer nanoparticles for osteosarcoma-targeted NIR-II fluorescence/NIR-I photoacoustic dual-model imaging and photothermal/photodynamic therapies
Journal of Nanobiotechnology (2022)
-
Active targeting via ligand-anchored pH-responsive strontium nanoparticles for efficient nucleic acid delivery into breast cancer cells
Journal of Pharmaceutical Investigation (2022)
-
Gas-stabilizing nanoparticles for ultrasound imaging and therapy of cancer
Nano Convergence (2021)
-
Multifunctional biomolecule nanostructures for cancer therapy
Nature Reviews Materials (2021)